Earnings Feed
Start Free
Home/Filings/4/0001209191-15-019974
4//SEC Filing

Mylan N.V. 4

Accession 0001209191-15-019974

CIK 0001623613operating
View on SEC.govCompany Profile

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 7:24 PM ET

Size

22.7 KB

Accession

0001209191-15-019974

Insider Transaction Report

Form 4
Period: 2015-02-27
Mylan N.V.MYL
Piatt Rodney L
Director
Transactions
  • Award

    Ordinary Shares

    2015-02-27+33,135→ 33,135 total
  • Award

    Non-Employee Director Stock Option - Right to Buy

    2015-02-27+19,994→ 19,994 total
    Exercise: $12.96Exp: 2018-04-25→ Ordinary Shares (19,994 underlying)
  • Award

    Non-Employee Director Stock Option - Right to Buy

    2015-02-27+14,286→ 14,286 total
    Exercise: $13.43Exp: 2019-05-07→ Ordinary Shares (14,286 underlying)
  • Award

    Non-Employee Director Stock Option - Right to Buy

    2015-02-27+11,626→ 11,626 total
    Exercise: $20.52Exp: 2020-05-14→ Ordinary Shares (11,626 underlying)
  • Award

    Non-Employee Director Stock Option - Right to Buy

    2015-02-27+10,864→ 10,864 total
    Exercise: $23.90Exp: 2021-05-06→ Ordinary Shares (10,864 underlying)
  • Award

    Non-Employee Director Stock Option - Right to Buy

    2015-02-27+13,158→ 13,158 total
    Exercise: $21.00Exp: 2022-05-04→ Ordinary Shares (13,158 underlying)
  • Award

    Non-Employee Director Stock Option - Right to Buy

    2015-02-27+6,623→ 6,623 total
    Exercise: $31.63Exp: 2023-05-28→ Ordinary Shares (6,623 underlying)
  • Award

    Non-Employee Director Stock Option - Right to Buy

    2015-02-27+2,974→ 2,974 total
    Exercise: $45.72Exp: 2024-04-11→ Ordinary Shares (2,974 underlying)
Footnotes (11)
  • [F1]On February 27, 2015 (the "Closing Date"), Mylan N.V. completed the transaction (the "Transaction") by which it acquired Mylan Inc. and Abbott Laboratories' ("Abbott") non-U.S. developed markets specialty and branded generics business (the "Business"). Pursuant to the terms of the Amended and Restated Business Transfer Agreement and Plan of Merger, dated as of November 4, 2014, by and among Mylan Inc., New Moon B.V. (which has been renamed Mylan N.V. and is referred to herein as "Mylan"), Moon of PA Inc. ("Merger Sub"), and Abbott, on the Closing Date, Mylan acquired the Business and Merger Sub merged with and into Mylan Inc., with Mylan Inc. surviving as a wholly owned indirect subsidiary of Mylan and each share of Mylan Inc. common stock issued and outstanding was cancelled and automatically converted into and became the right to receive one Mylan ordinary share (the "Merger"). (Continued in Footnote 2)
  • [F10]These options vested in full on May 28, 2014.
  • [F11]These options will vest in full on April 11, 2015.
  • [F2]In connection with the Transaction, Mylan Inc. and the Business have been reorganized under Mylan, a new public company organized in the Netherlands.
  • [F3]Represents ordinary shares of Mylan acquired in connection with the Transaction on a one-for-one basis in exchange for shares of Mylan Inc. common stock. On the effective date of the Merger, the closing price of MYL was $57.33 per share.
  • [F4]Received in exchange for, and having substantially the same terms as, stock options of Mylan Inc. common stock in connection with the Transaction.
  • [F5]These options vested in full on April 25, 2009.
  • [F6]These options vested in full on May 7, 2010.
  • [F7]These options vested in full on May 14, 2011.
  • [F8]These options vested in full on May 6, 2012.
  • [F9]These options vested in full on May 4, 2013.

Documents

1 file

Issuer

Mylan N.V.

CIK 0001623613

→
Entity typeoperating
IncorporatedNetherlands

Related Parties

1
  • filerCIK 0001623613

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 7:24 PM ET
Size
22.7 KB
View on SEC.gov